Tiger Jade Capital is a Private Equity fund focused on global healthcare industry. It is a comprehensive healthcare fund covering new drugs, CRO, medical equipment, etc. The Vision of Tiger Jade Capital is to save lives and make impact in people's well being via more innovative technologies.
READ MORETiger Jade Capital is a Healthcare focused private equity firm founded in 2019. Tiger Jade Capital aspires to aggregate conscious capital to improve people’s well being and contribute to community with total dedication and integrity; and as a result, deliver optimal returns for our investors. Click here to know more about our fund...
1. Strategically positioned for one of the leading high growth sectors in China. The medical expense in China is 6.2% of GDP, quite a big gap vs. 18% in US and 11% in Japan. In addition, development of commercial insurance and the inclusion of innovative drugs in the national health care system will help solve the payment issue and accelerate the innovation of new drugs.
2. Having Tigermed as a lead cornerstone investor, Tiger Jade is uniquely positioned to get exclusivity to top deals in health care area and orchestrate with other resources/industry funds aggregated by Tigermed.
3. Tiger Jade team provides first-class value-added services for the international operation of the fund in Hong Kong and post-investment management of the portfolio companies, providing more competitive advantages and growth potential for both the fund and investee companies.